• No results found

[PDF] Top 20 Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.

Has 10000 "Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy." found on our website. Below are the top 20 most common "Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.".

Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.

Autonomic dysfunction in chronic inflammatory demyelinating polyneuropathy.

... Chronic inflammatory demyelinating polyneuropathy (CIDP) is a common cause of autoimmune neuropathy, described first in 1958 by James Austin as steroid-responsive relapsing ...the ... See full document

92

Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy

Autonomic Dysfunction in Iraqi Patients with Chronic Inflammatory Demyelinating Polyneuropathy

... the autonomic disturbance in patients with chronic inflammatory demyelinating ...cardiovascular autonomic Ewing tests were performed for every patient in addition to the assessment of ... See full document

9

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy A double-blind, placebo-controlled, cross-over study

Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy A double-blind, placebo-controlled, cross-over study

... The results of the cross-over trial are summarized in Table 2. Complete data for the two treatment periods were available for 25 patients. Two patients improved after the first treatment[r] ... See full document

11

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

... the Inflammatory Neuropathy Consortium (INC), a standing committee of the Peripheral Nerve Society, and is a member of the Scientific Board of the Kreuth III meeting on the optimal use of plasma-derived medicinal ... See full document

15

Sural nerve T-cell receptor V gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy

Sural nerve T-cell receptor V gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy

... PCR analysis of V ␤ utilization in sural nerve and pe- ripheral blood. With the V ␤ primers and the PCR proto- col used in our study, we were able to detect expression of all TCR V ␤ gene families in peripheral blood of ... See full document

10

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada

... The model was also evaluated using dif- ferent assumptions about the utility gain from IVIG, the extrapolation of IVIG relapse rates, treatment switching for corticosteroid patients afte[r] ... See full document

9

Diagnostics of Sensory Ataxia in Patients with Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy from Republic of Sakha (Yakutia) and Krasnoyarsk Region

Diagnostics of Sensory Ataxia in Patients with Sensory Predominant Chronic Inflammatory Demyelinating Polyneuropathy from Republic of Sakha (Yakutia) and Krasnoyarsk Region

... activity chronic peripheral polyneuropathies, including sensory predominant chronic inflammatory demyelinating polyneuropathy ...[6]. Polyneuropathy with the affection of ... See full document

10

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab

... abnormalities in the lower extremities including absent sensory response in the right sural nerve, markedly slowed conduction velocities between the ankle and below the fibular head stimulation, severely reduced compound ... See full document

5

Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report

Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy: a case report

... Several pathological variants of GBS are recognised. AIDP represents 75% of cases and classically presents with ascending symmetrical paresis or paraesthesia, loss of deep tendon reflexes and autonomic ... See full document

5

<p>Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US</p>

<p>Two comparative assessments of intravenous immunoglobulin therapy switching patterns in the treatment of chronic inflammatory demyelinating polyneuropathy in the US</p>

... Study 1 required patients to receive IVIG as their fi rst treatment after diagnosis of CIDP, excluding patients who received all other CIDP-related therapies as their initial treatment. I[r] ... See full document

7

Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

Measuring disease activity and predicting response to intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy

... Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated neuropathy worldwide, with an estimated prevalence of 2–7 per 100,000 people ... See full document

8

Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report

Human immunodeficiency virus seroconversion presenting with acute inflammatory demyelinating polyneuropathy : a case report

... Several pathological variants of GBS are recognised. AIDP represents 75% of cases and classically presents with ascending symmetrical paresis or paraesthesia, loss of deep tendon reflexes and autonomic ... See full document

5

Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies

Deciphering immune mechanisms in chronic inflammatory demyelinating polyneuropathies

... Chronic inflammatory demyelinating polyneuropathy (CIDP) is an autoimmune disease of the periph- eral nerves and nerve ...common chronic autoimmune neuropathy in humans and is estimated ... See full document

13

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

... Any polyneuropathy of other causes, including multifocal motor neuropathy; monoclonal gammopathy of uncertain significance with anti myelin-associated glycoprotein IgM antibodies; hereditary demyelinating ... See full document

39

Isolated unilateral palatal and vocal cord palsy as an initial presentation of chronic inflammatory demyelinating polyradiculoneuropathy

Isolated unilateral palatal and vocal cord palsy as an initial presentation of chronic inflammatory demyelinating polyradiculoneuropathy

... of inflammatory cells in more than half in- dividuals [3, ...symmetrical polyneuropathy, predom- inantly distal features, exclusively sensory signs and symptoms, asymmetrical presentation, predominant ... See full document

5

Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children

Novel insight into Chronic Inflammatory Demyelinating Polineuropathy in APECED syndrome: molecular mechanisms and clinical implications in children

... CIDP: Chronic inflammatory demyelinating polineuropathy; CMAP: Compound muscle action potentials; EAN: Experimental autoimmune neuropathy; EMG: Electromyograhy; GBS: Guillan Barre Syndrome; IVIG: ... See full document

5

Association between autonomic dysfunction and olfactory dysfunction in Parkinson’s disease in southern Chinese

Association between autonomic dysfunction and olfactory dysfunction in Parkinson’s disease in southern Chinese

... as inflammatory, drug-induced, vascular and toxin-induced ...nose, chronic rhinitis, recent upper respiratory tract infec- tion and smoking were also ...cognitive dysfunction assessed by Chinese ... See full document

5

Child Neurology: Chronic inflammatory demyelinating polyradiculoneuropathy in children

Child Neurology: Chronic inflammatory demyelinating polyradiculoneuropathy in children

... NCS/EMG in patients with CIDP show evidence of a predominantly demyelinating polyneuropathy, typically in a segmental, or nonuniform pattern (fig- ure 1). Some axonal loss may be present. Demyeli- nating ... See full document

6

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

Overview of the pathogenesis and treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulins

... ber of autoimmune and inflammatory diseases. Although the presence of natural antibodies capable of recognizing foreign antigens could plausibly explain the role of IVIg in IgG replacement therapy, the precise ... See full document

5

CIDP Chronic Inflammatory Demyelinating Polyneuropathy. A publication of the GBS/CIDP Foundation International

CIDP Chronic Inflammatory Demyelinating Polyneuropathy. A publication of the GBS/CIDP Foundation International

... Peripheral nerves are bundles of nerve fibers called axons that connect the brain and spinal cord with the arms and legs. They carry electric- like impulses to muscles causing them to shorten or contract and relay ... See full document

14

Show all 10000 documents...